جست‌وجوی استاد و پژوهشگر

• Sepsis
• Innate Immunity
• Neonatal Immunology
• +۵ مورد دیگر

Andrew Currie is a Professor and Associate Dean (Research & Innovation) at Murdoch University's School of Medical, Molecular and Forensic Sciences, within the College of Environmental and Life Sciences. He leads the Sepsis Diagnostics Research Group at the Centre for Molecular Medicine and Innovative Therapeutics and co-heads the Neonatal Infection and Immunity Team with Clinical Professor Tobias Strunk at the Wesfarmers Centre of Vaccine & Infectious Diseases at Telethon Kids Institute. His research focuses on immunology and infectious diseases in pediatric populations, particularly sepsis diagnostics and neonatal immunity. Education: PhD (Immunology, University of Western Australia, 2001); BSc (Biotechnology with Honors, Murdoch University, 1997). Research Interests: Sepsis diagnostics, innate immunity mechanisms in neonates, medical biotechnology for diagnostics (e.g., biosensors), and translational research in pediatric infections. Collaborates internationally with institutions in Canada, Denmark, the UK, US, and China. Aims to reduce sepsis burden in vulnerable populations through advanced molecular methods and interdisciplinary partnerships. Key Affiliations: Lead of Sepsis Diagnostics Research Group (Murdoch University), Senior Lecturer in Immunology, Honorary Associate at Kids Research Institute Australia. Past roles include leadership in the Centre for Molecular Medicine and Innovative Therapeutics. Scientific Contributions: Over 100 peer-reviewed articles focusing on sepsis biomarkers, neonatal immunity, tick-borne diseases, and clinical trials for interventions like vitamin C and probiotics in critical illness. Active in developing precision medicine approaches for neonatal sepsis. Grants & Funding: Co-leads major projects on sepsis diagnostics and neonatal infection, supported by national and international grants. Collaborates on multi-institutional initiatives. Labs/Teams: Sepsis Diagnostics Research Group (Murdoch) and Neonatal Infection and Immunity Team (Telethon Kids Institute). Works closely with the Personalised Medicine Centre and Health Futures Institute.

Janin Chandraمشاهده پروفایل

عضو هیئت علمی

• Immunology
• Cancer Research
• Virology
• +۴ مورد دیگر

Dr. Janin Chandra is a Senior Research Fellow at the Frazer Institute, University of Queensland, leading her own lab since 2023. Her research focuses on immune regulation in HPV-driven cancers, antigen-presenting cells, and squamous cell carcinomas. She holds a PhD in Immunology from the University of Zurich and has extensive postdoctoral experience at UQ and biotech companies like Admedus Vaccines. She has published over 35 journal articles, contributed to clinical trials, and received the Garnett Passe Mid-Career Fellowship (2023–2027). Education: Master of Science (Goethe University, Frankfurt), PhD (University of Zurich). Research highlights include developing HPV vaccines, studying immune suppression mechanisms, and investigating Langerhans cell dysfunction in tumors. Her work bridges immunology and oncology, targeting therapies to modulate antigen-presenting cells. Research Interests : HPV-induced immune evasion mechanisms Antigen-presenting cell biology in cancer Clinical development of DNA vaccines Immune microenvironment of head/neck and cutaneous cancers Grants & Awards : Current funding includes targeting cancer-associated fibroblasts (Garnett Passe Fellowship). Past grants involve microbiome analysis and vaccine development. Lab Activities : Her lab investigates intra-tumor immune regulations and develops novel immunotherapies. Collaborations span veterinary oncology and microbiome research.

• Neurosciences
• Physiology
• Microbiology
• +۵ مورد دیگر

Professor Elisa Hill is a distinguished academic at RMIT University where she serves as a Professor in the Department of Health and Biomedical Sciences within the College of Science. She leads the Gut-Brain Axis Laboratory and holds the significant position of Deputy Chair of the Academic Board at RMIT University. Her career spans prestigious institutions including The University of Melbourne and research collaborations in Paris, France. Professor Hill earned her PhD in Neuroscience from The University of Melbourne in 2002. She subsequently undertook a CNRS postdoctoral position in Paris studying cortical neuronal diversity. Returning to Melbourne in 2006 as an NHMRC Howard Florey Centenary Fellow, she joined Prof Steve Petrou's laboratory to investigate neuronal networks in genetic mouse models of epilepsy. In 2009, she imported the Neuroligin-3R451C mouse model of autism to Australia, establishing herself as a pioneer in gut-brain axis research. Her research program focuses on three interconnected areas: identifying causes of gut dysfunction in transgenic mouse models of neurological disease, determining how neurons communicate with the lymphoid system and inflammation, and understanding interactions between the nervous system and bacteria. Professor Hill has demonstrated that gene variations associated with autism alter neuron populations in the mouse enteric nervous system, affecting gut motility, permeability, microbiome composition, and behavior. Her laboratory has developed sophisticated capabilities including video-imaging assays for gut motility, immunofluorescence for neuronal and immune cell analysis, and whole-cell patch clamp electrophysiology for neuronal activity profiling. Analysis of her recent publications reveals a strong focus on the gut-brain axis in autism, with particular attention to the Neuroligin-3R451C mouse model. Her work spans neuroimmunology, gastrointestinal physiology, microbiome interactions, and behavioral neuroscience, demonstrating an increasingly interdisciplinary approach that integrates molecular, cellular, and systems-level perspectives. A notable trend is the expansion of her research into translational applications, including biomaterial development for urogynaecological health. NHMMRC Howard Florey Centenary Fellowship ARC Future Fellowship RMIT Senior Vice Chancellor's Research Fellowship Professor Hill actively supervises numerous PhD students including Vic Lin, Yuansong Li, and Mohammed Al Alamoudi, among others. Her research has been supported by major funding bodies including NHMRC, US Department of Defense CDMRP, CNRS, ARC, and RMIT. She leads the Gut-Brain Axis Laboratory, which collaborates extensively with researchers across institutions, particularly with Prof Ashley Franks at La Trobe University. The laboratory employs a multidisciplinary team with expertise in neuroscience, microbiology, immunology, and gastrointestinal physiology, utilizing advanced techniques to investigate the complex interactions between the nervous system, immune system, and gut microbiome.

• Vascular Surgery
• Vascular Restenosis and Calcification
• Deep Venous Disease
• +۷ مورد دیگر

Associate Professor Christopher Delaney is an academic Vascular Surgeon affiliated with Flinders University's College of Medicine and Public Health and the Southern Adelaide Local Health Network. He serves as a Consultant Vascular Surgeon at Flinders Medical Centre and leads research within the Department of Vascular and Endovascular Surgery. Professor Delaney's research spans multiple areas of vascular medicine with particular focus on: Vascular surgery and endovascular techniques Vascular restenosis and calcification Deep venous disease and reconstruction Cardiovascular imaging techniques, particularly Intra-Vascular Ultrasound Breath metabolomics in cardiovascular disease Endothelial function Nutritional requirements of cardiovascular patients His recent publications demonstrate a strong focus on peripheral arterial disease, with research spanning from basic science investigations of vascular biology to clinical applications of novel endovascular technologies. His work particularly emphasizes the intersection of nutrition science and vascular disease, as well as innovative approaches to complex wound healing and limb salvage procedures. The establishment of a biobank for patients with peripheral arterial disease and cerebrovascular disease represents a significant advancement in his research program, enabling more comprehensive translational studies. Professor Delaney is an active HDR supervisor with registered supervisory interests in nutrition in surgery, vascular surgery, intra-vascular ultrasound, and vascular dysfunction. He serves as an investigator in several global clinical trials focused on reducing vascular restenosis rates using novel technologies, including a first-in-man trial for surgical arterio-venous fistulae. His research group maintains strong clinical connections through the Southern Adelaide Local Health Network and Flinders Medical Centre, where they translate research findings into improved patient care for complex vascular conditions including renal access surgery, deep venous reconstruction, and limb salvage procedures.

• Thrombosis
• Cardiovascular diseases
• Endothelial cell biology
• +۷ مورد دیگر

Associate Professor Freda Passam is a Clinical Academic Haematologist at Royal Prince Alfred Hospital, University of Sydney, specializing in thrombosis and haemostasis. She leads the Haematology Research Group at the Charles Perkins Centre, focusing on platelet biology, endothelial cell dysfunction, and translational research in cardiovascular diseases. Her work integrates basic science with clinical applications, including developing microfluidic technologies like the Endo-chip for thrombosis diagnosis and therapy screening. Education: MD and PhD in Greece (angiogenesis in Hodgkin’s lymphoma), postdoctoral training at UNSW and Harvard University. Research spans platelet hyperactivity in diabetes, immune thrombosis (e.g., HIT), and thiol isomerase inhibitors as antithrombotics. Collaborates globally with institutions like Harvard and the University of Utah. Research Interests: 1) Platelet biomarkers in diabetes-related cardiovascular risk; 2) Immune thrombosis diagnostics/therapies (e.g., Endo-chip); 3) Bone marrow-on-chip models for thrombopoiesis. Current projects include SEC61B regulation of calcium flux, endothelial thromboinflammation, and ERp5/ERp57 roles in platelet production. Grants: Over $6M in funding from NHMRC, MRFF, NSW Health, and industry partnerships. Notable awards include Sydney Nano Grand Challenge Award (2022) and SLHD VTE Stewardship Award (2020). Advising: Mentors over 6 PhD/master’s students in thrombosis research, emphasizing clinical/research integration. Teaching includes Sydney Medicine curriculum, bedside tutorials, and student engagement in lab activities. Labs/Teams: Haematology Research Group (Charles Perkins Centre), collaborations with Sydney Health Partners, Harvard, and international haematology groups. Develops technologies like the Endo-chip and bone marrow-on-chip models.

Jason Waithmanمشاهده پروفایل

دانشیار

• Cancer Immunology
• T Cell Immunity
• Dendritic Cell Biology
• +۳ مورد دیگر

Associate Professor Jason Waithman leads the Cancer Immunotherapy Program at the University of Western Australia's School of Biomedical Sciences. His expertise spans dendritic cell biology, T cell immunity, and cancer immunology. He holds dual affiliations with the School of Human Sciences and the Australian Centre for RNA Therapeutics in Cancer. Education: PhD in Immunology (University of Melbourne, 2008), specializing in CD8 T cell tolerance mechanisms. Research focuses on translational immunotherapy tools, genomic data science integration, and identifying novel therapeutic targets for cancer control. Key projects include CAR-T cell therapy optimization, immune response modulation in melanoma, and burn injury's impact on cancer immunity. Recent grants include leadership roles in skin cancer classification probes, high-content microscopy infrastructure, and natural killer cell enhancement therapies. He has authored 56 publications and 24 grants, with 4,513 citations and a h-index of 25. Labs/Teams: Cancer Immunotherapy Program, Australian Centre for RNA Therapeutics in Cancer. Collaborations span international institutions with a focus on immunology and oncology.

Stuart Robertsمشاهده پروفایل

عضو هیئت علمی

• Hepatology
• Chronic Viral Hepatitis
• Primary Liver Cancer
• +۹ مورد دیگر

Stuart Roberts is an Adjunct Clinical Professor in the Department of Gastroenterology at Monash University, Faculty of Medicine, Nursing and Health Sciences. He is actively engaged in clinical research focusing on liver diseases, with a strong emphasis on chronic viral hepatitis, primary liver cancer, non-alcoholic fatty liver disease (NAFLD/MASLD), and non-invasive liver diagnostics such as Fibroscan. University: Monash University School: Faculty of Medicine, Nursing and Health Sciences Department: Department of Gastroenterology Academic Rank: Adjunct Clinical Professor His research interests center on advancing therapeutic strategies for chronic liver diseases through clinical trials and translational studies. Key areas include evaluating novel antiviral and immunomodulatory agents for hepatitis B and C, assessing new treatments for hepatocellular carcinoma, and investigating metabolic and dietary influences on liver health in aging populations. He also studies the role of liver stiffness measurement in disease screening and prognosis. The recent publications and active research projects (2024–2025) reflect a strong trend toward understanding the intersection of liver disease with aging, cardiovascular health, and neurocognitive outcomes. His work increasingly focuses on metabolic dysfunction-associated steatotic liver disease (MASLD), its systemic complications, and lifestyle or pharmacological interventions. Multiple phase 1 to phase 3 clinical trials are underway, particularly in NASH/MASH, hepatitis B immunotherapy, and cholangiocarcinoma. Scientific Awards: No awards mentioned in the provided text. Advising and Grants: Dr. Roberts serves as Primary Chief Investigator on 42 research projects, including major industry-sponsored clinical trials in hepatology. His leadership in multicenter studies highlights his role in shaping evidence-based liver disease management. While no formal student advising is mentioned, his collaborations involve trainees and junior researchers. Funding appears to come from pharmaceutical sponsors and institutional sources, supporting trials in antiviral, metabolic, and oncologic liver therapies. Labs and Research Teams: Dr. Roberts leads a clinical research team focused on hepatology within Monash Health. His work is highly collaborative, involving dietitians, oncologists, geriatricians, and neurologists. The research network includes national and international partners, with a strong presence in Australian multicenter liver disease studies.

Danika Hillمشاهده پروفایل

پژوهشگر ارشد

• Immunology
• Vaccine Development
• Cellular and Molecular Mechanisms of Immunity
• +۵ مورد دیگر

Danika Hill is a Senior Research Fellow in the Department of Immunology and Pathology at Monash University. Her research focuses on understanding cellular and molecular mechanisms of immune responses to vaccination and infection, particularly in T follicular helper cells and germinal center biology. She investigates pathogens such as Group A Streptococcus, malaria, and influenza using advanced techniques like high-parameter flow cytometry and single-cell sequencing. Education: BSc in Biomedical Science (University of Adelaide), PhD (Walter and Eliza Hall Institute). Postdoctoral training at the Babraham Institute (Cambridge) before joining Monash in 2020. Funded by NHMRC CJ Martin Fellowship and Michelson Prize. Recognized as a 'Rising Star in Immunology' by the Norwegian Society for Immunology. Research Interests T follicular helper cell dynamics and germinal center regulation Long-lived antibody responses and vaccine design Age-related immune dysfunction Immune responses to infectious diseases Awards Michelson Prize (2020) Margaret Baird Women in Immunology Award (2022) NHMRC CJ Martin Fellowship (2018) Best Oral presentation awards (2020, 2022) Grants & Projects "Discovering molecular signatures of human T follicular helper cells and antibody-producing B cells" (NHMRC, 2018–2023) "Structure-based antigen design for mRNA vaccines" (2023–2025) Labs/Teams: Leads her own lab at Monash, collaborating internationally on vaccine efficacy and immune mechanisms.

• Biophotonics
• Nanotechnology
• Fluorescence Applications
• +۷ مورد دیگر

Professor Ewa Goldys is a distinguished academic at the University of New South Wales (UNSW), serving as a Professor in the School of Engineering with a focus on Biomedical Engineering. She holds the prestigious position of Deputy Director at the ARC Centre of Excellence for Nanoscale Biophotonics (CNBP), where she leads partnerships, knowledge transfer, and research commercialization efforts. Her work spans interdisciplinary research connecting engineering, medicine, and biology, with significant contributions to biophotonics and nanotechnology applications in healthcare. Professor Goldys' research interests center around advanced imaging techniques, particularly autofluorescence characterization, which provides a non-invasive metabolic 'fingerprint' for distinguishing healthy from diseased cells. Her work has significant applications in cancer, diabetes, and neurodegenerative diseases. She has pioneered research in fluorescent and luminescent nanomaterials for biological applications, developing innovative approaches for high-contrast, background-free imaging using time-gating techniques. Her research portfolio also includes significant contributions to CRISPR-based biosensing, stem cell characterization, and non-invasive diagnostic approaches using multispectral imaging. Her publication record demonstrates a clear trend toward increasingly sophisticated applications of autofluorescence imaging combined with machine learning and molecular techniques. Recent work integrates hyperspectral imaging with transcriptomics, develops CRISPR-based point-of-care diagnostics, and applies autofluorescence techniques to diverse medical challenges from kidney disease diagnosis to immune cell characterization. The interdisciplinary nature of her work spans oncology, immunology, nephrology, and regenerative medicine. Professor Goldys has received notable recognition for her work, including: Eureka award in 2016 for Innovative Use of Technology Her research leadership has secured substantial funding, including directing the $23 million ARC investment in the CNBP (matched by $17 million from partners), establishing the $2 million ARC/NHMRC Network 'Fluorescence Applications in Biotechnology and Life Sciences,' and leading research that leveraged an additional $155 million in external funding. She has founded the Optical Characterisation Facility at Macquarie University and has been instrumental in establishing international research networks in biophotonics. Professor Goldys has made significant contributions to the international biophotonics community through conference organization, having chaired 11 conferences including SPIE 'Biophotonics Australasia' and serving as Track Chair for Nanobiophotonics at BIOS, the world's largest biomedical optics meeting. Her work has established foundational methodologies in autofluorescence characterization that continue to drive innovation in label-free medical diagnostics.

• Physiology
• Metabolic Biochemistry
• Nutrition & Dietetics
• +۸ مورد دیگر

Dr. Vini Fernandes Cruzat is a Lecturer in Human Anatomy and Physiology at Southern Cross University’s Faculty of Health. He holds a PhD in Biomedical Science/Nutritional Biochemistry from the University of São Paulo and is a registered Nutritionist in Australia. His roles include Chair of the Queensland group of the Nutrition Society of Australia and Adjunct Senior Researcher at Griffith University. Academic Background: Bachelor in Exercise and Sport Science (Lutheran University of Brazil) Graduate Certificate in Learning and Teaching (Torrens University Australia) Master of Science in Nutritional Biochemistry (University of São Paulo) Dr. Cruzat’s research focuses on the metabolic, antioxidant, and anti-inflammatory effects of nutrient supplementation, particularly amino acids like glutamine, arginine, and leucine, as well as vitamin D and bioactive compounds from spent coffee grounds. He investigates cellular mechanisms in diabetes associated with obesity, emphasizing oxidative stress, insulin resistance, and heat shock protein pathways. His recent work explores the therapeutic potential of coffee byproducts and vitamin D in metabolic disorders. His publications over the past five years highlight a consistent focus on amino acid metabolism, oxidative stress in diabetes, and the intersection of nutrition/exercise with inflammation. Key trends include molecular studies of beta-cell dysfunction, clinical trials on supplementation, and applications of coffee compounds in functional food development. Dr. Cruzat has supervised 3 PhD, 6 MSc, and 5 Honours students across Australian and international institutions. He teaches human anatomy, physiology, and metabolic biochemistry and contributes to research networks in diabetes and exercise physiology.

• Thrombosis
• Haematology
• Cardiovascular Medicine
• +۵ مورد دیگر

Professor Denise Jackson is a faculty member in the Department of Health and Biomedical Sciences at RMIT University, Bundoora West campus. She serves as the Head of the Thrombosis and Vascular Biology laboratory and holds an honorary fellowship from the National Health and Medical Research Council (NHMRC). Her research focuses on thrombosis mechanisms, platelet biology, and immunoreceptor roles in infection and immunity. She coordinates courses such as MEDS1142 Medical Informatics, BUSM3220 Medical Laboratory Quality Systems, and ONPS2153 Medical Informatics and Laboratory Management. Research Interests: Professor Jackson’s work spans thrombosis, platelet function, mouse models of thrombus formation, and the molecular mechanisms of immunoreceptors in pathogens. Her team investigates tetraspanins’ role in blood clot regulation and signaling pathways in platelets. Key projects include studying tyrosine kinase inhibitors’ effects on haemostasis and exploring immunoreceptor crystal structures for drug design. Professional Involvement: She reviews grants for NHMRC, National Heart Foundation, and international bodies like the Wellcome Trust and NSF. She also serves as a reviewer for journals including Nature and Blood . Student Supervision: Principal supervisor of 12 Honours, 3 Masters, and 4 PhD students. Labs/Teams: Leads the Thrombosis and Vascular Biology lab, collaborating on drug development and thrombosis prevention strategies.

• Anterior Eye Imaging
• Diabetic Neuropathy
• Neurobiology of Ocular Surface Symptoms
• +۳ مورد دیگر

Dr. Katie Edwards is an Associate Professor in the School of Clinical Sciences at Queensland University of Technology (QUT), specializing in Optometry and Vision Science. She holds a PhD from the University of New South Wales (UNSW) and has contributed extensively to research on anterior eye disease, diabetic neuropathy, and ocular surface symptoms. Her work bridges clinical practice and translational research, focusing on corneal imaging as a biomarker for systemic conditions. Edwards leads the Anterior Eye Lab and serves as Associate Editor for Clinical and Experimental Optometry . Her research interests include cellular imaging of the anterior eye, systemic disease markers, and neurobiology of ocular symptoms. Notable contributions include studies on corneal nerve changes in diabetes and the role of the ocular surface in systemic health. Edwards has received the Juvenile Diabetes Research Foundation Postdoctoral Fellowship (2013) and has authored over 20 peer-reviewed articles. Teaching focuses on anterior eye anatomy, physiology, and disease management. Her lab investigates cutting-edge techniques such as in vivo confocal microscopy and explores clinical applications of ocular findings to broader health diagnostics.

• Immunology
• Cancer Research
• Tumor Microenvironment
• +۳ مورد دیگر

Hannah Newnes is a Research Associate at the School of Biomedical Sciences, The University of Western Australia. Her work focuses on immunology and cancer research, particularly the role of type I interferons in antitumor immunity and immunotherapy. She is affiliated with the University of Western Australia (M503) and holds an ORCID ID (0000-0003-1647-975X). Current position: Research Associate Institution: The University of Western Australia Research focus: Immunotherapy, Tumor Microenvironment, Interferon Signaling Research Interests: Hannah's research explores how type I interferons modulate immune responses in cancer contexts. Key areas include: Differential activation of immune cells (T cells, NK cells) via interferon subtypes Mechanisms linking burn injury to cancer incidence Overcoming therapeutic resistance in tumor microenvironments Immunomodulatory cytokines (e.g., interleukin-4) in cancer treatment Systems-level understanding of immune-cancer interactions Translational immunotherapy for solid cancers Research Output Trends: Her publications (9 total) span 2021–2025, with recent emphasis on type I interferon subtypes, T cell activation, and tumor microenvironment in high-impact journals like Science Advances and Cancers . Collaborative work with teams across immunology, oncology, and biomedical sciences dominates her output. Grants: She contributed to a Cancer Council WA-funded project (2024–2025) titled Enhancing T cell-based immunotherapies for solid cancers . Contact: Email: hannah.newnes@uwa.edu.au

• Epidemiology
• HIV
• Sexually Transmitted Infections
• +۴ مورد دیگر

Lei Zhang is a Professor (Research) and Head of the Artificial Intelligence and Modelling in Epidemiology Program at the School of Translational Medicine, Monash University, Australia. He holds adjunct roles at institutions like Tsinghua University and is a consultant to the WHO Western Pacific Region. His expertise spans HIV/STI epidemiology, mathematical modelling, and AI-driven healthcare solutions. Education: Bachelor of Advanced Science in Mathematics (University of Sydney, 2001) Master of Science in Applied Mathematics (University of Sydney, 2003) PhD in Medicine (UNSW, 2006) Master of Public Health (Hamburg University of Applied Sciences, 2009) Research Interests: Prof. Zhang focuses on cross-disciplinary research in HIV/STI epidemiology, AI applications for disease modeling and diagnostics, health economics, and global health policy. His work integrates mathematical models with clinical data to optimize interventions and inform policy. Key Projects: HOPE: Optimizing HIV Pre-Exposure Prophylaxis (PrEP) in East Asia WHO Collaborations: Supporting global STI programs and policy development China-Australia Joint Research Center for Infectious Diseases Awards: 2021 ASRHA Innovation Award for HIV/STI research contributions Advising & Grants: Supervised 21 students (6 PhD, 15 MSc) and currently co-supervises 24 students (11 PhD, 13 MSc). Leader of 5+ major research grants, including NHMRC-funded projects on STI control and diabetes research. Labs/Teams: Leads the AI & Modelling in Epidemiology Program and collaborates with global networks like UNAIDS, the World Bank, and ministries of health across the Western Pacific region.

• Neurodegenerative Disorders
• Clinical Neurophysiology
• Diabetic Neuropathies
• +۷ مورد دیگر

Professor Cindy Lin is the inaugural Kam Ling Barbara Lo Chair in Neurodegenerative Disorders at the University of Sydney's Faculty of Medicine and Health, affiliated with the Brain and Mind Centre. She holds qualifications in Biomedical Engineering (Auckland University) and completed her PhD in Neurosciences at UNSW Sydney. Her career bridges engineering and clinical neuroscience, with postdoctoral training at University College London. She specializes in neurophysiological techniques like threshold tracking, clinical biomarker development for neurodegenerative disorders, and translational research across pediatric to aging populations. Research interests include diabetic neuropathies, neuromuscular diseases, immune-mediated neuropathies, and chemotherapy-induced neurotoxicity. She leads international collaborations with institutions in Taiwan, Japan, and the UK, focusing on biomarker development and clinical translation. Key projects include studying CIDP immunotherapy responses, diabetic neuropathy biomarkers, and SMA outcome measures. Her awards include the NHMRC CJ Martin Fellowship and grants from USYD-NTU and USYD-FUDAN partnerships. She supervises postgraduate students and trains clinicians in nerve excitability techniques globally. Current collaborations involve CSL Behring for IVIG research and Dexcom for diabetic neuropathy monitoring. Affiliations: Brain and Mind Centre, Central Clinical School Education: PhD (UNSW Sydney), MEngSci (UNSW), BE (Auckland University) Grants: Multiple international grants including dementia roadmap projects and neuroimaging collaborations Key Collaborations: National Taiwan University, Chiba University, UCL London